D-Calcium

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of D-Calcium

Quick Facts

Property Description
Active ingredients Calcium Carbonate, Dihydrotachysterol (DHT)
Form Oral solid form (Tablet or Capsule)
Pharmacological class Antihypocalcemic agent, Vitamin D analog
Common use Calcium homeostasis maintenance and deficiency support
Origin Mineral (Calcium Carbonate) and Synthetic (Dihydrotachysterol)

What Type of Medicine is D-Calcium?

D-Calcium is a fixed-dose combination pharmaceutical preparation classified as an Antihypocalcemic agent and a Calcium regulator, administered via the oral route. This combination integrates two necessary components: the mineral substrate and a potent regulatory agent, setting it apart from standard single-ingredient supplements.

The formulation is derived from two distinct sources: the mineral Calcium Carbonate and the synthetic compound Dihydrotachysterol (DHT), which is identified as a Vitamin D analog. This synthetic component is often recognized in pharmacological studies for its utility in managing specific endocrine imbalances.

Understanding the Active Ingredients: Composition and Function

The efficacy of D-Calcium stems from the synergistic action of its two active ingredients: Calcium Carbonate and Dihydrotachysterol (DHT). Calcium Carbonate provides the fundamental elemental calcium required for bone structure and neurological function.

Dihydrotachysterol is the key regulatory component that enhances the body's efficiency in absorbing calcium from the intestine and promoting its mobilization within the body. Its use is clinically recognized for providing more reliable calcium homeostasis maintenance compared to pure calcium salts alone.

What is the General Purpose of D-Calcium?

The general purpose of D-Calcium is to regulate calcium levels and support the structural integrity of the skeletal system by preventing or correcting mineral deficiencies. The dual mechanism ensures that the body receives and efficiently utilizes the essential mineral required for calcium homeostasis maintenance.

By actively addressing mineral requirements and supporting metabolic regulation, D-Calcium provides robust support for overall mineral metabolism. For instance, it is typically employed to maintain adequate bone mineral density in patients requiring chronic calcium and Vitamin D analog support.

Regulatory References

  1. Calcium | MedlinePlus

What side effects are possible with D-Calcium?

Possible Side Effects and Safety Information

The safety profile of D-Calcium (a fixed-dose combination of Calcium Carbonate and Dihydrotachysterol) is primarily defined by the risk of hypercalcemia (elevated blood calcium levels), which is the most significant and expected adverse reaction documented in regulatory labeling. This risk is central to how official documents classify and communicate the medicine's safety characteristics.


Adverse Reaction Classifications

Adverse effects are documented across several System-Organ Classes, reflecting the drug's systemic impact:

  • Metabolic and Nutritional Disorders: Hypercalcemia and hypercalciuria (excess calcium in urine).
  • Gastrointestinal Disorders: Effects such as nausea, vomiting, constipation, and dry mouth are commonly noted.
  • Renal and Urinary Disorders: These can include polyuria (increased urination) and, with severe or chronic hypercalcemia, potential impairment of renal function.

Frequency Classification: Hypercalcemia and hypercalciuria are often classified as uncommon (affecting 1 in 100 to 1 in 1,000 users), while certain gastrointestinal issues like constipation may be classified as rare.


Serious Adverse Reactions and Safety Constraints

Official labeling documents specify the potential for severe hypercalcemia, which is linked to serious outcomes including cardiac arrhythmias and, rarely, seizures. Chronic elevation of calcium can also lead to long-term risks such as generalized soft-tissue calcification and severe renal impairment.

Time-Related Safety Patterns: Regulatory notes indicate that signs of early hypercalcemia may include headache, metallic taste, and bone pain, while severe calcification is associated with long-term exposure. Safety restrictions officially contraindicate the use of D-Calcium in patients with pre-existing hypercalcemia, known hypersensitivity to the ingredients, and in cases of severe renal impairment. The safety notes also indicate that concurrent use with certain medications, such as cardiac glycosides, necessitates caution and monitoring.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of D-Calcium, which includes calcium and its vitamin D components, results primarily in hypercalcemia (abnormally high blood calcium levels). This condition typically arises from ingesting higher-than-recommended amounts of supplements or prescribed medication.

Documented Overdose Symptoms

The clinical manifestations of overdose are due to hypercalcemia and can affect multiple organ systems. Early symptoms often include nausea, vomiting, abdominal pain, constipation, increased thirst, and frequent urination. More severe presentations that indicate serious risk can involve confusion, profound fatigue, muscle weakness, and disturbances in heart rhythm.

Emergency Actions and Attention

Immediate medical help is required if you suspect an overdose or experience severe symptoms such as collapse, difficulty breathing, or signs of an irregular heartbeat. In the event of an overdose, you should:

  • Call the Poison Control Helpline immediately.
  • Seek emergency medical attention right away if severe symptoms are present.

Overdose, while sometimes not immediately life-threatening, can lead to serious, long-term complications including kidney stones and permanent kidney damage if not treated promptly.

Therapeutic Uses of D-Calcium

Quick Facts: D-Calcium

  • May help support the maintenance of strong bone structure.
  • Used in therapeutic strategies to assist in managing conditions associated with low calcium levels.
  • Contributes to normalizing body functions dependent on balanced calcium.

D-Calcium is an agent used to address nutritional needs related to calcium intake. Its primary therapeutic domains involve supporting the maintenance of healthy bone mass and assisting in the prevention of bone deterioration. Adequate calcium intake throughout life, including through supplementation when necessary, may help reduce the risk of osteoporosis in later years. The substance is also used to manage or prevent conditions characterized by inadequate calcium in the blood, which can influence various critical body processes.

Additionally, D-Calcium may contribute to the normal function of muscles and nerves and plays a role in supporting blood clotting processes. The body requires sufficient calcium levels to facilitate normal cardiovascular and neuromuscular activity.

Eligibility and Restrictions for Use

Who Can and Cannot Use D-Calcium

The eligibility for D-Calcium (Calcium Carbonate and Dihydrotachysterol) is strictly defined by regulatory documents, focusing on patient health status and risk of calcium imbalance. Use is contraindicated for patients with pre-existing Hypercalcaemia or Hypervitaminosis D.


Contraindications and Restrictions

Population Status Regulatory Rule
Absolute Contraindications Patients with Severe Renal Impairment, Hypercalcaemia, Hypervitaminosis D, or known Hypersensitivity to the active ingredients. Breastfeeding mothers are also contraindicated.
Age-Group Rules Use in children and adolescents (0–18 years) is often not intended or contraindicated in fixed-dose formulations due to the potency of the Vitamin D analog component.
Conditional Use Patients with non-severe Impaired Renal Function, Sarcoidosis, or Cardiac Function Impairment must use the medicine with caution and require close, regular monitoring of mineral levels.
Pregnancy Status Classified as Pregnancy Category C; use is only justified if the potential benefit outweighs the possible risk to the fetus.

The regulatory profile emphasizes that the risk of elevated calcium levels associated with the Dihydrotachysterol component drives most eligibility exclusions and requires careful patient selection for established indications like Hypoparathyroidism or Hypocalcemia.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes documented interaction patterns between D-Calcium and other medicinal products, foods, or supplements, based on official regulatory labeling. All information is presented at a high, regulatory-aligned descriptive level, strictly excluding clinical recommendations or interpretation.


Official Interaction Statements

Classification Interacting Substance/Class Official Interaction Outcome
Contraindicated Other Vitamin D Compounds (analogues/metabolites) Significant additive risk of hypercalcemia
Pharmacodynamic Cardiac Glycosides (e.g., Digoxin) Hypercalcemia risk potentiates digitalis toxicity, increasing arrhythmia risk
Pharmacodynamic Thiazide Diuretics Increased risk of hypercalcemia due to reduced calcium excretion
Pharmacokinetic Microsomal Enzyme Inducers (e.g., Phenobarbital) May officially reduce the half-life of the Dihydrotachysterol component

Administration Timing and Absorption Interference

The most significant interaction pattern involves the physical binding (chelation) of the calcium component with other medicines, which formally reduces the absorption and systemic exposure of the co-administered drug. This interaction requires mandatory time separation of administration.

Medicines requiring separation include Tetracycline and Fluoroquinolone Antibiotics, Bisphosphonates, and Levothyroxine. These must be administered at least two to six hours apart from D-Calcium, depending on the specific agent, as stated in regulatory documents.

Absorption of the lipid-soluble Dihydrotachysterol component can also be impaired by co-administration with bile acid sequestrants like Cholestyramine.


Dietary and Supplemental Constraints

Certain food components, specifically Oxalic acid (in spinach/rhubarb) and Phytic acid (in whole grains), are officially documented to inhibit calcium absorption. Furthermore, high intake of Phosphate supplements can increase the risk of soft tissue calcification.

Mechanism of Action

D-Calcium, as a mineral supplement, exerts its mechanistic effects by contributing the essential calcium ion (Ca^2+) substrate required for fundamental physiological processes. Its action is centered on regulating calcium homeostasis across multiple systems.


Modulation of Calcium Transport and Metabolism

D-Calcium provides the necessary mineral to support the dynamic equilibrium of calcium concentration, acting as a crucial component of the calcium-vitamin D-parathyroid hormone (PTH) axis. This supply influences the processes that govern intestinal absorption, renal reabsorption, and bone mobilization of Ca^2+, thereby modifying systemic bioavailability.


Role in Cellular Signaling and Excitability

In cellular domains, the calcium ion functions as a critical second messenger. D-Calcium modulates Ca^2+ availability for processes dependent on its precise concentration and flux. This mechanism includes influencing the electrochemical gradient across excitable cell membranes, which is necessary for the propagation of action potentials and the controlled release of neurotransmitters in neural and muscle tissue.


Extracellular Matrix Integration

Structurally, calcium is required as the primary mineral substrate for the calcification of the bone matrix. This involvement contributes to the required structural organization and rigidity of the skeletal system.

Dosage and Administration Information

The administration of D-Calcium, which combines Dihydrotachysterol (DHT) and Calcium Carbonate, is standardized around a precise, two-phase oral dosing regimen. This pattern is established to ensure the proper utilization of the active components.

Administration Scope

Instruction Detail
Route of administration Oral only.
Dosing schedule The regimen includes an Initial/Loading Phase of 0.8 mg to 2.4 mg of DHT orally once daily for approximately four days, followed by a Maintenance Phase typically ranging from 0.2 mg to 1.0 mg of DHT orally once daily.
Timing in relation to meals May be taken before or after meals.
Preparation requirements If using the oral solution, it must be measured with a calibrated dropper.
Missed-dose rules If a scheduled dose is missed, skip the missed dose and resume the normal schedule; the dose should not be doubled.

Procedural Structure and Context

The treatment protocol is based on once daily administration and requires concurrent, adequate calcium supplementation to function effectively, as the DHT component regulates the body’s use of the co-administered calcium. The medicine is subject to a strict titration schedule, where dose adjustments are made slowly over intervals of four to eight weeks, guided by frequent monitoring of serum calcium levels. Specific dosing rules are also established for certain populations, including documented regimens for pediatric patients and neonates, and the drug's use in patients with renal impairment requires close and careful dose adjustment. These explicit instructions define the standardized manner in which the drug is utilized.

Recent Clinical Evidence

Research Evidence / Overview of Studies for D-Calcium

The research base for D-Calcium—a product containing Calcium Carbonate and the synthetic Vitamin D analog Dihydrotachysterol (DHT)—explores the effects of the combination on mineral levels and bone markers. Studies monitor how patients' internal levels of calcium and related markers change under specific conditions.


Evidence for Use in Chronic Hypoparathyroidism

Research exploring the use of D-Calcium, specifically its component DHT, was studied for patients with chronic hypoparathyroidism. This is a condition where the body does not produce enough Parathyroid Hormone (PTH).

Clinical Trials (RCTs) and older long-term observational studies have focused on this patient group, which often includes adults and, in some research, children. These studies monitored outcomes like serum calcium and phosphate concentrations, researching patterns of mineral level change in the population. Studies report measurements related to measured shifts in mineral markers. Findings described patterns of adjustments observed in managing laboratory values.

What remains uncertain is the need for more recent, contemporary head-to-head Randomized Controlled Trials (RCTs). Because DHT is a well-established but older treatment, there is limited direct comparative evidence against some of the newest treatment options now available. Furthermore, the reliance on older observational studies and case reports means that long-term effects are not fully established through contemporary controlled study designs.


Evidence for Use in General Calcium Deficiency States

D-Calcium was evaluated in research related to general hypocalcemia (low calcium levels) and researching changes in bone mineral density (BMD). This research often uses Meta-analyses that combine data from various RCTs. These studies explored populations such as elderly adults with low calcium levels, and individuals with bone conditions like osteomalacia or rickets.

The outcomes monitored included changes in the rate of serum calcium in the blood, as well as structural indicators like shifts in BMD over time. Research describes changes measured during the study period for both the biochemical markers and the physical markers of bone health. A key limitation is the heterogeneity across studies. Much of the available evidence is pooled from trials that included a variety of different Vitamin D analogs, meaning D-Calcium-specific (DHT) long-term data for general deficiency may be limited.

Frequently Asked Questions (FAQ)

Common questions about D-Calcium (FAQ)


Q: Is D-Calcium the same as regular calcium supplements?

Official documents describe D-Calcium as a combination product. It contains the mineral Calcium Carbonate and the synthetic regulatory compound Dihydrotachysterol. This combination, which includes an active analog, makes it distinct from supplements that only contain calcium.


Q: Can D-Calcium be taken instead of a standard calcium pill?

Regulatory documents indicate that concurrent, adequate calcium supplementation is required as part of the therapeutic plan for D-Calcium. This is because the Dihydrotachysterol component helps regulate the body’s use of the calcium that is administered. Your healthcare provider determines the total calcium intake required for your specific condition.


Q: What is the difference between D-Calcium and Vitamin D?

D-Calcium contains Dihydrotachysterol, which is classified as a synthetic Vitamin D analog. It is described in regulatory sources as functioning similarly to Vitamin D but without requiring the same chemical activation in the kidney. This is a characteristic that is considered when prescribing the medicine for conditions where standard Vitamin D may not be effective.


Q: Does D-Calcium cause changes in weight?

Regulatory documents list weight loss as a potential adverse effect associated with high blood calcium levels, known as hypercalcemia. Hypercalcemia is the primary risk linked to D-Calcium use. Weight gain is not explicitly listed as a side effect.


Q: Can D-Calcium be taken at the same time as coffee or tea?

Official product information notes that certain food components, such as Oxalic acid (found in some teas) and Phytic acid, can reduce the absorption of calcium. The medication is generally designed to be taken before or after meals, and the potential for reduced absorption is a factor to consider in the overall administration plan.


Q: Is it safe to take D-Calcium with iron supplements or multivitamins?

Official warnings caution that taking calcium or vitamin D supplements or multivitamins containing these ingredients alongside D-Calcium may cause your blood calcium levels to rise too high. This additive effect is why disclosure of all concurrent supplements to a healthcare provider is noted in official warnings.


Q: Is D-Calcium safe for use during pregnancy?

The medicine is classified as Pregnancy Category C by regulatory bodies. This category indicates that use during pregnancy is only justified if the potential benefit is judged to outweigh the possible risk to the fetus. This assessment is based on animal studies showing potential for fetal abnormalities.


Q: Can children take D-Calcium under certain circumstances?

Yes. Official regulatory documents include documented regimens for using the medication in neonates, infants, and children for specific prescribed conditions, such as certain forms of rickets or hypoparathyroidism. The specific use is highly controlled.


Q: Is D-Calcium typically prescribed for long-term use?

Dihydrotachysterol is noted in regulatory documents to exert a slow but persistent effect in the body, and the medicine may be used for extended periods. Long-term use requires close and regular monitoring of blood calcium levels to ensure safety.


Q: How quickly is D-Calcium supposed to start showing an effect?

According to official pharmacokinetic data, the onset of action for the Dihydrotachysterol component typically occurs within 24 to 48 hours after administration. This indicates how soon the body begins to regulate calcium levels in response to the medicine.


Q: Why would a doctor recommend D-Calcium over simply adjusting one's diet?

D-Calcium is indicated for conditions such as Hypoparathyroidism and specific forms of Rickets. Regulatory descriptions indicate these conditions often require potent mineral regulation that extends beyond simple dietary changes to correct or maintain proper calcium homeostasis.


Q: Is feeling tired a known side effect listed for D-Calcium?

Fatigue and weakness are listed in official documents as early signs or symptoms of hypercalcemia (high blood calcium levels). This linkage to the primary adverse reaction is why these symptoms are documented in official safety information.


Q: Can patients with high blood pressure safely use D-Calcium?

Hypertension (high blood pressure) is listed in regulatory sources as a potential later sign of severe hypercalcemia. Due to the risk of calcium level elevation, patients with pre-existing heart or circulatory conditions require careful monitoring during therapy.


Q: Is D-Calcium considered a high-risk medication based on its safety profile?

Official regulatory documents indicate that the difference between the therapeutic dose and the toxic dose may be small. This means the dosage must be highly individualized and carefully controlled by regular determinations of blood calcium levels to prevent potential toxicity.


Q: What happens in general if a patient suddenly stops taking D-Calcium?

Regulatory information notes that the effects of Dihydrotachysterol can persist in the body for up to one month after treatment has been discontinued. This sustained effect is why monitoring may continue after stopping the medication.


Q: Does D-Calcium contain gluten or common allergens?

Official documents that list inactive ingredients for the tablet form include components such as lactose and starch. For specific allergies or intolerances, the full list of inactive ingredients should be reviewed against individual needs.

How should D-Calcium be stored and disposed of?

How to Store and Dispose of D-Calcium?

The official storage and disposal guidelines for D-Calcium are defined by the product's regulatory profile, which emphasizes security, stability, and environmental protection.

Official Storage Requirements

The medicine must be stored locked up and out of the sight and reach of children, reflecting the mandatory security requirements for potent substances. Storage must be in a cool, dry, and well-ventilated location, away from heat sources and foodstuffs. The container must remain tightly closed to protect the integrity of the contents.

Official Disposal Instructions

Official regulations require that D-Calcium waste avoid release to the environment and must not be discharged to sewer systems or wastewater. Unused or expired product and its container must be disposed of at an approved waste disposal plant in accordance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of D-Calcium found in:

A-Z Index: